Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Number of new cancer pharmaceuticals approved by EMA in Sweden 2014-2017

Number of new cancer pharmaceuticals approved by EMA (European Medicines Agency) in Sweden from 2014 to 2017

by F. Norrestad, last edited Feb 12, 2019
Number of new cancer pharmaceuticals approved by EMA in Sweden 2014-2017 This statistic shows the number of new cancer pharmaceuticals approved by EMA (European Medicines Agency) in Sweden from 2014 to 2017. The number peaked in 2015, reaching nine new approved cancer pharmaceuticals. In 2017, one new cancer pharmaceutical approved by EMA was on the Swedish market.
Show more

Number of new cancer pharmaceuticals approved by EMA (European Medicines Agency) in Sweden from 2014 to 2017

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.